Abbott Laboratories (ABT)
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
$113.60-1.65%
Close 2026-11-05 · 1-day change
NYSEHealth CareMedical - DevicesSnapshot 2026-11-04
QuarterlyIQ Insights · ABT
What must go right, what could break, what the price assumes, and what evidence comes next.
The current health of the standing investment case.
Recent financial performance is holding in the top half of its industry — the reason to own it looks intact.
One-year growth currently built into the price, compared with our model's estimate.
| Measure | Marker shape | Value |
|---|---|---|
| Growth built into the price | circle | 2.5% |
| Our one-year growth estimate | diamond | 13.0% |
For each item: what to watch, what would become a concern, and what would make it less concerning.
A reporting-risk estimate, not a forecast of the stock-price response.
Historical relationships that met the evidence threshold. They do not prove cause or forecast a move.
No outside relationship met the current evidence threshold.
Based on historical daily prices through 2026-11-04.
Past price behavior in dollars on a $10,000 position. This does not measure permanent business risk.
How much price usually moves either way.
A larger daily loss that occurred about once in every 20 trading days.
Use the underlying financial and sector pages to investigate the cause.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Growth built into the price is above our model estimate.
The price assumes 10.5 percentage points less one-year growth.
The one-year revenue growth assumption on Valuation.
Model as of 2026-11-04 · Compared with 28 industry peers · Company calendar date is not available
ABT — earnings miss
Dated 2026-10-21
Results of Operations and Financial Condition On October 21, 2026, Abbott Laboratories announced its results of operations for the third quarter 2026. Furnished as Exhibit 99.1, and incorporated herein by reference, is the news release issued by Abbott announcing those results. In that news release, Abbott uses various non-GAAP financial measures including, among others, net earnings excluding specified items. These non-GAAP financial measures adjust for factors that are unusual or unpredicta…
Why it matters: Abbott cut its 2026 sales growth view to about 6.0% from 6.5% to 7.5%. A higher result would show stronger growth than its latest view.
Supportive ifFull-year 2026 comparable sales growth tops 6.0%.
Worry ifFull-year 2026 comparable sales growth is reported at 6.0% or less.
Why it matters: Abbott bought Exact Sciences in March. Cancer Diagnostics grew 13.8% in Q3, but the supplied updates do not show savings yet.
Supportive ifAbbott reports at least $100 million in annual pre-tax savings from Exact Sciences by 2028.
Worry ifAbbott reports less than $100 million in annual pre-tax savings by 2028, or delays the target.
Why it matters: Medical Devices grew 7.8% in Q3, below its Q2 and Q1 rates. A further slowdown would weaken a key growth area.
Worry ifQ4 Medical Devices sales growth is below 7.8%.
Less concerning ifQ4 Medical Devices sales growth is 7.8% or higher.
Why it matters: U.S. Nutrition fell 4.5% over the first nine months, then grew 7.9% in Q3. A new drop would signal that the rebound did not last.
Worry ifU.S. Nutrition comparable sales growth is below 0% in a later quarter.
Less concerning ifU.S. Nutrition comparable sales growth stays at or above 0% in each reported quarter.
We watch for confirming and disproving signals on each item. Resolutions are found automatically where possible and checked by hand for unclear cases. Last 90 days shown.
Deepest peak-to-trough drop in the last year.
| Measure | Value | Meaning |
|---|---|---|
| Typical day | ±$112 on $10,000 · ±1.1% | How much price usually moves either way. |
| Bad day | $227 loss on $10,000 · 2.3% | A larger daily loss that occurred about once in every 20 trading days. |
| Largest peak-to-trough drop in the past year | $3,606 loss on $10,000 · 36.1% | Deepest peak-to-trough drop in the last year. |
Past year. 1.00 means similar movement; 1.20 means about 20% more.
Past year. 1.00 means similar movement to the sector. This is secondary context.
Latest 30 trading days, shown as an annual percentage.
Latest 252 trading days, shown as an annual percentage.
20-trading-day average in US dollars.
Trading days used by the source risk snapshot.
Past results, not a forecast. Not investment advice.